CEO Thomas Polen framed the quarter as execution strength following the Life Sciences separation, saying, "Earlier today, we reported strong Q4 results with revenue of $5.3 billion, up 5.6% and 27.3% growth in adjusted
CryptoAlerta — análise de criptomoedas e mercado em tempo real